logo
Share SHARE
FONT-SIZE Plus   Neg

Threshold Issues Updated Results From Phase 2 Study Of TH-302 - Quick Facts

Threshold Pharmaceuticals, Inc. (THLD: Quote) announced updated results from a Phase 2 study of TH-302, the company's investigational hypoxia-targeted drug, in patients with soft tissue sarcoma, including additional results from patients who were administered TH-302 as single agent maintenance therapy following induction with TH-302 in combination with doxorubicin.

In the single-arm Phase 2 component of the study, previously untreated patients with metastatic or locally advanced unresectable soft tissue sarcomas were treated with TH-302 and doxorubicin for a maximum of six cycles. After six cycles, patients with stable disease, partial or complete responses, and with acceptable toxicity, were eligible to receive TH-302 maintenance therapy. Response was assessed using RECIST criteria.

In overall study population, results for the 91 patients in the Phase 2 component of the study include median progression free survival of 6.7 months, median overall survival of 21.5 months, one-year survival of 73% and two-year survival of 44% and overall best response of 36%.

The company also reported results for TH-302 single agent maintenance therapy population. The median number of treatment cycles with TH-302 was 4.0. Median PFS was 3.7 months. Median overall survival was 18 months. Overall best response was 54%.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Mitel Networks Corp. (MITL, MNW.TO) and Mavenir Systems (MVNR) announced a merger agreement in which Mitel will acquire all of the outstanding shares of Mavenir common stock in a cash and stock deal valued at approximately $560 million. Get ahead of the market. For in-depth analysis not... ISIS has renewed its death threat to employees of micro-blogging site Twitter, Inc., particularly its co-founder Jack Dorsey. The threats are in retaliation for Twitter blocking accounts which are affiliated to or support the Islamic State. Twitter has a policy of barring users from posting threats or using the service for furthering of illegal activities. Solar module make JinkoSolar Holding Co., Ltd. (JKS) reported a profit for the fourth quarter that rose from last year, driven by a nearly 36 percent rise in revenues. Get ahead of the market. For in-depth analysis not available anywhere else, check out our
RELATED NEWS
Trade THLD now with 
Follow RTT